Abstract:Cytochrome P450 2C9 (CYP2C9) is one of the most abundant CYP enzymes in the human liver. CYP2C9 metabolizes more than 100 therapeutic drugs, including tolbutamide, glyburide, diclofenac, celecoxib, torasemide, phenytoin losartan, and S-warfarin). Some natural and herbal compounds are also metabolized by CYP2C9, probably leading to the formation of toxic metabolites. CYP2C9 also plays a role in the metabolism of several endogenous compounds such as steroids, melatonin, retinoids and arachidonic acid. Many CYP2C9 substrates are weak acids, but CYP2C9 also has the capacity to metabolise neutral, highly lipophilic compounds. A number of ligand-based and homology models of CYP2C9 have been reported and this has provided insights into the binding of ligands to the active site of CYP2C9. Data from the site-directed mutagenesis studies have revealed that a number of residues (e.g. Arg97, Phe110, Val113, Phe114, Arg144, Ser286, Asn289, Asp293 and Phe476) play an important role in ligand binding and determination of substrate specificity. The resolved crystal structures of CYP2C9 have confirmed the importance of these residues in substrate recognition and ligand orientation. CYP2C9 is activated by dapsone and its analogues and R-lansoprazole in a stereo-specific and substrate-dependent manner, probably through binding to the active site and inducing positive cooperativity. CYP2C9 is subject to induction by rifampin, phenobarbital, and dexamethasone, indicating the involvement of pregnane X receptor, constitutive androstane receptor and glucocorticoid receptor in the regulation of CYP2C9. A number of compounds have been found to inhibit CYP2C9 and this may provide an explanation for some clinically important drug interactions. Tienilic acid, suprofen and silybin are mechanism-based inhibitors of CYP2C9. Given the critical role of CYP2C9 in drug metabolism and the presence of polymorphisms, it is important to identify drug candidates as potential substrates, inducer or inhibitors of CYP2C9 in drug development and drug discovery scientists should develop drugs with minimal interactions with this enzyme. Further studies are warranted to explore the molecular determinants for ligand-CYP2C9 binding and the structure-activity relationships.

Establishment of the Recombinant Human Cytochrome P450 2C9 Saccharomyces Cerevisiae Expression Systems in Vitro and the Impact of Gene Polymorphism on Drug-Drug Interactions

Identification and Functional Assessment of EightCYP3A4Allelic Variants39–46Detected in the Chinese Han Population

Study on the Effects of Human CYP450 3A4 Allelic Polymorphism on Drug Metabolisms and Drug-Drug Interactions in Vitro

Expression and Enzymatic Analysis of the Human Cytochrome CYP1A2 in Saccharomyces cerevisiae

Evaluation of the Effects of 18 Non-Synonymous Single-Nucleotide Polymorphisms of CYP450 2C19 on in Vitro Drug Inhibition Potential by a Fluorescence-Based High-Throughput Assay.

[CYP2D61, CYP2D610 Co-Expressed with CYPOR in Bac-to-Bac Expression System and Activity Determination].

Identification and in vitro functional assessment of 10 CYP2C9 variants found in Chinese Han subjects

Advance in Genetic Polymorphism of Cytochrome P450 2C19

Progress in research of cytochrome P450 3A4 gene polymorphism

Polymorphisms of Human Cytochrome P450 2c9 and the Functional Relevance

Study on the Effect of Three CYP2C9 Variants on Drug–Drug Interaction Related to Six Drugs in Vitro by LC–MS/MS Method

[Heterogeneous expression of human CYP and its application in early stage of new drug research and development].

Influence Of Various Polymorphic Variants Of Cytochrome P450 Oxidoreductase (Por) On Drug Metabolic Activity Of Cyp3a4 And Cyp2b6

Expression and Characterization of Human Cytochrome P450 1A2

Advances in Study of CYP2B6 Gene Polymorphisms and Its Functional Significances

The Effects Of Cytochrome P450 2c19 Polymorphism On The Metabolism Of Voriconazole In Vitro

Functional Characterization of Five CYP2C8 Variants and Prediction of CYP2C8 Genotype-Dependent Effects on in Vitro and in Vivo Drug-Drug Interactions.

Substrates, Inducers, Inhibitors and Structure-Activity Relationships of Human Cytochrome P450 2C9 and Implications in Drug Development

In Vitro Functional Analysis of 24 Novel Cyp2c19 Variants Recently Found in the Chinese Han Population

Recent Advance of Cytochrome P450 2C9

In Vitro Functional Characterization of 37 CYP2C9 Allelic Isoforms Found in Chinese Han Population.